Tweets
CLE to SLE transition occurred more frequently in pts aged 40 and younger, w/in the first 10 years of dx, and those with SCLE. Abs 0338 #ACR22 @RheumNow https://t.co/XxHjkNL5Hf https://t.co/1WtgmVM7Iz
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
Saxena et al Zetomipzomib, a selective immunoproteasome inhibitor in lupus nephritis. Phase 2 study. UPCR=<0.5 achieved 64.7% week 37, pred=<10mg/day 82.4% week 13. @RheumNow #ACR22 Abstr#0992 https://t.co/askpmqsYYG https://t.co/cKoR0bgtWt
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Wallace @zach_wallace_md et al. IgG4-RD in USA. Incidence 1.2/100,000, prevalence 2.8/100,000. Pancreas (43.0%), biliary tract (30.6%), salivary glands (11.7%), retroperitoneum (5.0%). HR 2.51 for mortality in IgG4-RD. @RheumNow #ACR22 Abstr#0713 https://t.co/IpjSKxmHQN
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Opioid use in adults with PsA and AS
Abstract #0402 @RheumNow #ACR22
✋828 PsA patients ➡️ 21% used opioids
🦴 334 AS patients ➡️ 27% used opioids
💊Opioid users had more comorbidities, more medical visits, worse disease activity, and higher prevalence of 🚬
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 8 months ago
Manansala et al. Baseline lymphopenia negatively predicts disease severity in sarcoid. It is protective for decline in FBC. @RheumNow #ACR22 Abstr#0830 https://t.co/Q4fE9LoG9L https://t.co/Tt1PyYLfWu
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Ross et al. Comorbid liver disease significantly attenuates CRP rise with disease flare. Increased BMI increases CRP rise. @RheumNow #ACR22 Abstr#0811 https://t.co/O3PsDfbCMV https://t.co/9xAqWTJqkf
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Fat and bone health are related via adipokines (fat hormones).
Data from VA registry of RA pts:
clear relationship between elevated adipokines & osteoporotic fracture risk.
This is why body fat should be a target for osteoporosis management
ABST0889 @PennRheum #ACR22 @RheumNow https://t.co/BoP8d4sooZ
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
Vural et al Rituximab biosimilar switch in GPA. Essentially it is the same. @RheumNow #ACR22 Abstr#1072 https://t.co/OBOMz35soX https://t.co/dPdcWQmBzd
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Soussi et al. Over last 20 years, 5-year all-cause morality decreased in RA and controls in Danish study. But to greater extent in RA, narrowing mortality gap. @RheumNow #ACR22 Abstr#0711 https://t.co/JRh37u3uGm https://t.co/bA3Y5FLcRZ
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Have you heard of MyPROSLE (available at https://t.co/a4zlBtwaaC)? Abs 0329 details MyPROSLE's molecular characterization of individual SLE pts and it's extraction of key molecular information to support more precise therapeutic decisions. #ACR22 @RheumNow https://t.co/FslQCVvptw https://t.co/NNlgZvllPC
Links:
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
🔥ignite session🔥
❓Vessel wall MRI superior to TA-US in c-GCA❓
🔥In c-GCA vessel wall MRI examines beyond the temporal arteries -
✅more 🧠 cranial arteries, including occipital arteries and the all important 👁 orbital structures
Abst#0473
#ACR22 @RheumNow https://t.co/z8hYmqc95I
Patricia Harkins @DrTrishHarkins ( View Tweet )
3 years 8 months ago
Carter et al. Case series showing rapid effect of anifrolumab in refractory discoid lupus and SCLE. @RheumNow #ACR22 Abstr#0974 https://t.co/Od1PXzJKQh https://t.co/Hk8mrblGMX
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
